Acute myeloid leukemia targets for bispecific antibodies (vol 7, e522, 2017)

被引：0
|
作者：
Hoseini, S. S.
Cheung, N. K.
机构：
来源：
BLOOD CANCER JOURNAL | 2017年 / 7卷
关键词：
D O I：
10.1038/bcj.2017.35
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Correction to: Blood Cancer Journal (2017) 7, e522; doi:10.1038/bcj.2017.2; published online 3 February 2017 Following the online publication of this article, the authors noted that the following funding information needed to be included: This work was supported through the NIH/NCI Cancer Center Support Grant P30 CA008748.
引用
收藏
页码：e552 / e552
页数：2
相关论文
共 50 条
  • [1] Acute myeloid leukemia targets for bispecific antibodies
    S S Hoseini
    N K Cheung
    Blood Cancer Journal, 2017, 7 : e522 - e522
  • [2] Acute myeloid leukemia targets for bispecific antibodies
    Hoseini, S. S.
    Cheung, N. K.
    BLOOD CANCER JOURNAL, 2017, 7 : e522 - e522
  • [3] Erratum: Acute myeloid leukemia targets for bispecific antibodies
    S S Hoseini
    N K Cheung
    Blood Cancer Journal, 2017, 7 : e552 - e552
  • [4] Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia
    Guy, Daniel G.
    Uy, Geoffrey L.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (06) : 417 - 425
  • [5] Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia
    Daniel G. Guy
    Geoffrey L. Uy
    Current Hematologic Malignancy Reports, 2018, 13 : 417 - 425
  • [6] CD33 directed bispecific antibodies in acute myeloid leukemia
    Clark, Mary C.
    Stein, Anthony
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2020, 33 (04)
  • [7] Bispecific antibodies in acute lymphoblastic leukemia therapy
    Chitadze, Guranda
    Laqua, Anna
    Lettau, Marcus
    Baldus, Claudia D.
    Brueggemann, Monika
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (11) : 1211 - 1233
  • [8] Advancing cancer care and prevention in the Caribbean: a survey of strategies for the region (vol 20, pg e522, 2019)
    Spence, D.
    Argentier, M. A.
    Andall-Brereton, G.
    LANCET ONCOLOGY, 2019, 20 (11): : E613 - E613
  • [9] Simulated net-benefit of polymerase chain reaction test for COVID-19 among asymptomatic patients (vol 7, e522, 2020)
    Okada, Y.
    Kiyohara, K.
    Kitamura, T.
    ACUTE MEDICINE & SURGERY, 2020, 7 (01):
  • [10] THERAPEUTIC TARGETS FOR ACUTE MYELOID LEUKEMIA (AML)
    Sorbera, L. A.
    Verges, C.
    Dulsat, C.
    DRUGS OF THE FUTURE, 2009, 34 (01) : 67 - 77
12345